These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31403901)

  • 1. Provider-patient communication about prescription drug abuse: A qualitative analysis of the perspective of prescribers.
    Mathis SM; Hagaman A; Hagemeier N; Baker K; Pack RP
    Subst Abus; 2020; 41(1):121-131. PubMed ID: 31403901
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interprofessional prescription opioid abuse communication among prescribers and pharmacists: A qualitative analysis.
    Hagemeier NE; Tudiver F; Brewster S; Hagy EJ; Ratliff B; Hagaman A; Pack RP
    Subst Abus; 2018 Jan; 39(1):89-94. PubMed ID: 28799863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors.
    Hagemeier NE; Tudiver F; Brewster S; Hagy EJ; Hagaman A; Pack RP
    Res Social Adm Pharm; 2016; 12(6):937-948. PubMed ID: 26806859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "It's Took Over This Region": Patient Perspectives of Prescription Drug Abuse in Appalachia.
    Mathis SM; Hagemeier N; Foster KN; Baker K; Pack RP
    Subst Use Misuse; 2020; 55(1):37-47. PubMed ID: 31526177
    [No Abstract]   [Full Text] [Related]  

  • 6. Trauma Trainees' Multiple Competing Goals in Opioid Prescription Communication.
    Adams ET; Cohen EL; Bernard A; Darnell W; Helme DW
    Qual Health Res; 2018 Nov; 28(13):1983-1996. PubMed ID: 29984621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.
    Irvine JM; Hallvik SE; Hildebran C; Marino M; Beran T; Deyo RA
    J Pain; 2014 Jul; 15(7):747-55. PubMed ID: 24787089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using prescription dispensing data infographics to facilitate collaborative pharmacist-prescriber discussions on mutual patients.
    Carroll JC; Renner HM; McGivney MS; Grapsy J; McCormick K; Cooney SS; Coley KC
    J Am Pharm Assoc (2003); 2019; 59(2):232-237.e1. PubMed ID: 30638731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of prescriber risk indicators obtained from prescription drug monitoring program data.
    Kreiner PW; Strickler GK; Undurraga EA; Torres ME; Nikitin RV; Rogers A
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S31-S38. PubMed ID: 28363317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-care practitioner use of prescription drug monitoring programs in clinical practice in Australia: A qualitative study.
    Hoppe D; George Liu C; Khalil H
    Drug Alcohol Rev; 2023 Nov; 42(7):1647-1657. PubMed ID: 37402606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the number of multiple prescribers for opioids utilizing data from the California Prescription Monitoring Program.
    Wilsey BL; Fishman SM; Gilson AM; Casamalhuapa C; Baxi H; Lin TC; Li CS
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1262-8. PubMed ID: 21448897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers.
    Chang HY; Murimi IB; Jones CM; Alexander GC
    Addiction; 2018 Apr; 113(4):677-686. PubMed ID: 29193546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring perspectives on changing opioid prescribing practices: A qualitative study of community stakeholders in the HEALing Communities Study.
    Walker DM; Childerhose JE; Chen S; Coovert N; Jackson RD; Kurien N; McAlearney AS; Volney J; Alford DP; Bosak J; Oyler DR; Stinson LK; Behrooz M; Christopher MC; Drainoni ML
    Drug Alcohol Depend; 2022 Apr; 233():109342. PubMed ID: 35151024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges faced with opioid prescriptions in the community setting - Australian pharmacists' perspectives.
    Makdessi CJ; Day C; Chaar BB
    Res Social Adm Pharm; 2019 Aug; 15(8):966-973. PubMed ID: 30819418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
    Fink PB; Deyo RA; Hallvik SE; Hildebran C
    Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention.
    McCauley JL; Leite RS; Melvin CL; Fillingim RB; Brady KT
    Subst Abus; 2016; 37(1):9-14. PubMed ID: 26675303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Payor-Mandated Review of Prescription Drug Monitoring Program on Opioid Prescriber Rates.
    Schumann SO; Zhang J; McCauley JL; Heidari K; Ball SJ
    South Med J; 2020 Sep; 113(9):415-417. PubMed ID: 32885255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in prescription drug monitoring program use by prescriber specialty.
    Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
    J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.